瑞马唑仑在临床应用中的安全性和有效性研究进展

ResearchProgress on the Safetyand Efficacy of Remimazolam in Clinical Application/LIU Shuai， ZHANG Weiwei.//Medical Innovationof China，2025，22（17）：161-165

[Abstract]Remimazolam is a very short-acting intravenous benzodiazepine （BZD） drug developed by the pharmaceutical company PAION AG.In clinical application， compared with other anesthetic and sedative drugs， suchas MidazolamandPropofol，Remimazolamhas theadvantagesofrapidonset，highclearancerate，shortduration ofaction，quickrecovery，stablehemodynamicsandsmallrespiratoryinhibitoryeffct.Thisarticlereviewsthe pharmacological characteristics and clinical application research of Remimazolam，providing a reference for safe clinical medication.

[Key words] Remimazolam Safety Efficacy

First-author'sddress：epartmentofnesthesiology，inzhouedicalUversityHospital，hou 256603， China

doi：10.3969/j.issn.1674-4985.2025.17.037

在安全性方面，瑞马唑仑（Remimazolam，CNS7056）的血流动力学作用稳定，对呼吸和心血管系统的抑制作用较小]。（剩余13066字）